
Sai Parenteral's IPO: From GMP to key dates, price band, peers and more - 10 key things to know before subscribing
Sai Parenteral's ₹409 crore IPO is set to open for subscription from March 24 to March 27, 2026, with a price band of ₹372–₹392 per share. The pharmaceutical formulations company plans to utilize the fresh issue proceeds for manufacturing expansion, a new R&D center, and acquiring an Australian pharma firm. The IPO consists of a fresh issue of ₹285 crore and an offer for sale by existing shareholders worth ₹124 crore. Retail investors can participate with a minimum lot size of 38 shares, requiring an investment of ₹14,896. While the grey market premium currently sits at zero, the company holds a strong position in therapeutic areas like cardiovascular and anti-diabetic care. The tentative listing date is scheduled for April 2, 2026, on both the NSE and BSE. The company faces competition from established players like Gland Pharma and Innova Captab.





